{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:19:35Z","timestamp":1780571975621,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ajog.2011.06.056","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T18:25:43Z","timestamp":1317320743000},"page":"S4-S8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"S","title":["The state of hormonal contraception today: established and emerging noncontraceptive health benefits"],"prefix":"10.1016","volume":"205","author":[{"given":"Karla","family":"Maguire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2011.06.056_bib1","series-title":"Preventing pregnancy, protecting health: a new look at birth control choices in the United States","author":"Harlap","year":"1991"},{"key":"10.1016\/j.ajog.2011.06.056_bib2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/AOG.0b013e3181fdfb11","article-title":"Pregnancy-related mortality in the United States, 1998 to 2005","volume":"116","author":"Berg","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-120-10-199405150-00002","article-title":"Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study","volume":"120","author":"Colditz","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2011.06.056_bib4","doi-asserted-by":"crossref","first-page":"c927","DOI":"10.1136\/bmj.c927","article-title":"Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study","volume":"340","author":"Hannaford","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2011.06.056_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.contraception.2010.04.006","article-title":"Factors affecting mortality in a large cohort study with special reference to oral contraceptive use","volume":"82","author":"Vessey","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.06.056_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/bmj.1.5179.1103","article-title":"Treatment of functional menstrual disorders with norethisterone","volume":"1","author":"Bishop","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.ajog.2011.06.056_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1479-828X.1991.tb02769.x","article-title":"Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia","volume":"31","author":"Fraser","year":"1991","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0002-9378(92)91676-2","article-title":"Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic","volume":"166","author":"Robinson","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.AOG.0000165826.03915.65","article-title":"Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial","volume":"106","author":"Davis","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003989.pub4","article-title":"20 microg versus >20 microg estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2011.06.056_bib11","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/humrep\/del162","article-title":"Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone","volume":"21","author":"Milsom","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2011.06.056_bib12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.06.056_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.1974.03230260042022","article-title":"Negative association confirmed surgically","volume":"228","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2011.06.056_bib15","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/0002-9378(87)90028-7","article-title":"Phasic contraceptive pills and functional ovarian cysts","volume":"156","author":"Caillouette","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9378(92)91371-G","article-title":"Oral contraceptive type and functional ovarian cysts","volume":"166","author":"Lanes","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0002-9378(11)91570-1","article-title":"A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development","volume":"167","author":"Young","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0010-7824(95)00096-S","article-title":"Ovarian function during low-dose oral contraceptive use","volume":"51","author":"Egarter","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.06.056_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/152.3.242","article-title":"Oral contraceptive and benign ovarian tumors","volume":"152","author":"Westhoff","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2011.06.056_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001019.pub2","article-title":"Modern combined oral contraceptives for pain associated with endometriosis","author":"Davis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2011.06.056_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2011.06.056_bib22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2011.06.056_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2106\/00004623-197557050-00014","article-title":"Bone mineral: effects of oral contraceptives, pregnancy, and lactation","volume":"57-A","author":"Goldsmith","year":"1975","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.ajog.2011.06.056_bib24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(98)09044-8","article-title":"Oral-contraceptive use and risk of hip fracture: a case-control study","volume":"353","author":"Michaelsson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2011.06.056_bib25","first-page":"297","article-title":"World Health Organization","volume":"80","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ajog.2011.06.056_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study","volume":"159","author":"Wise","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2011.06.056_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.293.6543.359","article-title":"Risk factors for uterine fibroids: reduced risk associated with oral contraceptives","volume":"293","author":"Ross","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ajog.2011.06.056_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub4","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2011.06.056_bib30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.ajog.2011.06.056_bib31","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2006.05.012","article-title":"Oral contraceptives and premenstrual symptoms: comparison of a 21\/7 and extended regimen","volume":"195","author":"Coffee","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006033.pub3","article-title":"Steroidal contraceptives: effect on bone fractures in women","author":"Lopez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2011.06.056_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(79)91435-1","article-title":"\u201cIncessant ovulation\u201d and ovarian cancer","volume":"2","author":"Casagrande","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2011.06.056_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral-contraceptive use","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2011.06.056_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","article-title":"Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives","volume":"152","author":"Ness","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2011.06.056_bib36","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2011.06.056_bib37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM198003063021004","article-title":"Incidence of endometrial cancer in relation to the use of oral contraceptives","volume":"302","author":"Weiss","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2011.06.056_bib38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ijc.25050","article-title":"Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition","volume":"127","author":"Dossus","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2011.06.056_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<191::AID-IJC7>3.0.CO;2-F","article-title":"A cohort study of oral contraceptive use and risk of benign breast disease","volume":"82","author":"Rohan","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2011.06.056_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a113089","article-title":"Risk factors for benign breast disease","volume":"113","author":"Brinton","year":"1981","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2011.06.056_bib41","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2011.06.056_bib42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/01.AOG.0000284446.22251.6e","article-title":"Oral contraceptives and the risk of death from breast cancer","volume":"110","author":"Wingo","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.056_bib43","first-page":"703","article-title":"Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study","volume":"71","author":"Potter","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2011.06.056_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humupd\/dmp017","article-title":"Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis","volume":"15","author":"Bosetti","year":"2009","journal-title":"Hum Reprod Update"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937811007915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937811007915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:32:16Z","timestamp":1762079536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937811007915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0002937811007915"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2011.06.056","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The state of hormonal contraception today: established and emerging noncontraceptive health benefits","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2011.06.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}